Aims/hypothesis Targeted metabolomic and transcriptomic approaches were used to evaluate the relationship between skeletal muscle metabolite signatures, gene expression profiles and clinical outcomes in response to various exercise training interventions. We hypothesised that changes in mitochondrial metabolic intermediates would predict improvements in clinical risk factors, thereby offering novel insights into potential mechanisms. Methods Subjects at risk of metabolic disease were randomised to 6 months of inactivity or one of five aerobic and/or resistance training programmes (n=112). Pre/postintervention assessments included cardiorespiratory fitness
Introduction
Exercise training provides a wealth of health, cardiovascular and metabolic benefits with skeletal muscle serving as the major organ responsible for these metabolic adaptations [1] [2] [3] [4] . At a cellular level, aerobic physical activity enhances both the quantity and quality of muscle mitochondria, which in turn augments oxidative capacity and exercise tolerance [5] . Although muscle mitochondrial biogenesis and remodelling are generally presumed to contribute to exercise-induced improvements in glucose and lipid control, the molecular basis of this link remains poorly understood.
The advent of 'omics' technology affords new opportunities to shed light on mechanisms of disease as well as those underlying the health benefits of physical activity. In recent years, both unbiased and targeted metabolomics approaches have proven useful for gaining new insights into the pathogenesis of chronic metabolic disorders, including obesity, type 2 diabetes and cardiovascular disease [6, 7] . Metabolic profiling allows identification of metabolite signatures that track specific disease states and intervention outcomes. For example, comprehensive analysis of circulating metabolic intermediates linked exercise traininginduced improvements in insulin sensitivity to increased levels of plasma glycine and proline and reductions in plasma acylcarnitines [8] . These metabolic signatures can be used to guide mechanistic studies and/or pinpoint potential therapeutic targets [6, 7] . Herein, we sought to apply a similar, yet tissue-specific, approach to better understand the salutary metabolic consequences of habitual physical exercise training.
The present study used mass spectrometry to inventory changes in muscle quantities of several mitochondrial intermediary metabolites in response to exercise training. We hypothesised that training-induced adaptations in skeletal muscle would be evident at the metabolite level and questioned whether changes in mitochondrial metabolic intermediates would predict improvements in clinically relevant outcomes. The study was conducted in a group of sedentary, overweight-to-obese men and women enrolled in the Studies of Targeted Risk Reduction Interventions through Defined Exercise (STRRIDE) trials [3] .
Methods
Participants This investigation included 112 participants who were part of the first and second STRRIDE trials conducted in 1998-2003 and 2004-2009 , respectively. For these trials, participants were between ages 18 and 70 years, inactive (not participating in regular exercise), overweight to mildly obese (BMI 25-35 kg/m 2 ) and dyslipidaemic (LDL-cholesterol level of 3.34-4.92 mmol/l [130-190 mg/dl] or HDL-cholesterol <1.04 mmol/l [40 mg/dl] for men and <1.17 mmol/l [45 mg/dl] for women). Participants were excluded if they had diagnosed diabetes mellitus or fasting glucose >6.99 mmol/l (126 mg/dl), hypertension (BP >160/90 mmHg), known cardiovascular disease, musculoskeletal conditions that prohibited exercise training, used tobacco or medications known to affect carbohydrate or lipid metabolism or followed a dietary regimen designed to induce weight loss [3] . For this secondary analysis, participants were selected randomly from those who completed the intervention and had skeletal muscle available for measurement of metabolic intermediates.
Exercise training Participants were randomised to continued inactivity or to one of the following supervised aerobic exercise training groups: low-amount moderate-intensity exercise (5,021 kJ/week [1,200 kcal three sets/day, eight to 12 repetitions/set of upper and lower body exercises using Cybex machines); and the linear combination of low-amount vigorous-intensity exercise and RT all with continuous progression and performed primarily under observation in a local fitness centre [4, 9] . At baseline, a maximal exercise test was used to determine participants' V ⋅ O 2peak , maximum heart rate and heart-rate range corresponding to the prescribed intensity. To minimise musculoskeletal injury, participants completed a ramp period where they exercised within the prescribed heart-rate range while weekly exercise amounts (minutes) were progressed. At the end of the ramping phase, maximal and submaximal exercise tests verified that the heart-rate range corresponded to the correct percentage V ⋅ O 2peak ;
after this, participants exercised at the assigned exercise training prescription for a total of 6 months. Thus, progression occurred by using heart-rate ranges such that as the fitness of the participants improved, to maintain the same heart rate, the work-rate increased. Exercise training compliance was verified by recorded activity with heart-rate monitors (Polar Electro, Woodbury, NY, USA) and visual supervision.
Metabolic, cardiovascular risk factor and dietary assessments As described previously [2] , at baseline and the conclusion of training, participants completed a maximal cardiopulmonary treadmill test to determine cardiorespiratory fitness (V ⋅ O 2peak ).
A frequently sampled intravenous glucose tolerance test was performed in all participants, after they had been fasted for 12 h, at baseline and at the conclusion of training (16-24 h after the last exercise bout) or inactivity. Insulin (Access Immunoassay System; Beckman Coulter, Fullerton, CA, USA) and glucose (YSI model 2300 Stat Plus; Yellow Springs Instruments, Yellow Springs, OH, USA) were measured and an insulin sensitivity index (S I ) was derived based on Bergman's Minimal Model [3, 10] . Triacylglycerol (TG) measurements were performed on fasted plasma samples using nuclear magnetic resonance (Liposcience, Cary, IN, USA [4] ).
Participants were counselled to maintain dietary stability and verification was performed with 3 day food records and 24 h dietary recall interviews at baseline, mid-intervention and at training conclusion.
Skeletal muscle metabolites Before and at the conclusion of the intervention training (16-24 h after the last exercise bout), vastus lateralis needle biopsies were performed in fasted participants using a modified Bergstrom technique [11] . Samples were snap frozen and stored at −80°C. Tissue was diluted 20-fold (mass : volume) in ice-cold water, minced with surgical scissors and homogenised for 30 s using a rotor-stator tissue disruptor.
A targeted, mass-spectrometry-based platform was used to measure a total of 15 amino acids, 45 acylcarnitines and seven organic acids as previously described [12, 13] . For analyses of amino acids and acylcarnitines, samples were precipitated with methanol, esterified and analysed with tandem mass spectrometry (MS/MS). Organic acids were measured with gas chromatography-mass spectrometry (GC/MS) [13] .
Gene expression Gene expression arrays were performed in half (n=57) of the 112 participants, evenly distributed among groups and sexes. Total RNA was extracted from skeletal muscle biopsies using Trizol (Invitrogen, Carlsbad, CA, USA) and 30-50 mg of starting material. Two-round amplification of total RNA was performed using Affymetrix kits (Affymetrix, Santa Clara, CA, USA). A total of 30 μg of biotinylated cRNA from the second amplification round was hybridised to Affymetrix U133 Plus 2.0 microarrays. Data processing of resultant CEL (cell intensity) files is described below. As previously described, quality controls included adequate amplifications, thresholds for appropriate scaling factors and controls for RNA integrity (GAPDH 3′/5′ and HSACO7 3′/5′ ratios) [14, 15] . If a sample did not meet all quality control values after processing through microarray, it was reprocessed from the original total RNA sample, after the integrity of the RNA sample was verified by agarose gel electrophoresis and imaging. For probe set analysis, probe set means were generated from the PLIER (probe logarithmic intensity error) algorithm (typically six iterations) in Expression Console (Affymetrix). PLIER is a model-based signal estimator beneficial to multiarray estimations. Figure 1 shows the average change in skeletal muscle metabolites measured in the fasted state, grouped according to the intervention regimen. Training-induced changes in the individual metabolites in muscle were most pronounced in the high-amount/vigorous and RT plus low-amount/vigorous-intensity groups while changes were minimal in the RT group. These results reflect the targeted nature of our analysis, which focused heavily on mitochondrial intermediates. As compared with the inactive control group, high-amount/vigorous-intensity training produced marked statistically significant increases (60-312%) in skeletal muscle concentrations of several even-chain acylcarnitines, primarily medium-and long-chain species generated as byproducts of β-oxidation (C6, C4DC, C8, C6DC, C10:2, C10, C12:1, C12, C14:2, C14:1, C14, C16:2, C16:1, C18:1) ( Fig. 1; p<0 .01 for all post hoc tests). Similarly, RT plus low-amount/vigorous-intensity training also increased several short-and medium-chain acylcarnitine species (C2, C4/C4i, C4OH, C6, C4DC, C6DC, C10:1, C10, C7DC, C10OH/C8DC, C12:1, C12, C12OH/C10DC, C14:2, C14:1, C14, C14OH/C12DC, C16:2, C16:1, C16, C16:1OH/ C14:1DC, C18:2, C18:1, C18:1OH/C16:1DC) in the range of 40-488% ( Fig. 1; p<0 .01 for all post hoc tests). By contrast, the glycolytic metabolites, lactate and pyruvate, and most organic acid intermediates of the tricarboxylic acid (TCA) cycle were unaffected by exercise training, with the exception of succinate, which appeared to increase dose dependently, with an 85% increase in the highamount/vigorous-intensity group (Fig. 1, p<0 .01 for all post hoc tests). Table 2 shows results from parametric testing.
Data analysis
Training-induced changes in muscle metabolites correlated with clinical outcomes Whereas average changes in clinical outcomes and muscle metabolite levels are depicted by group in Tables 1 and 2 , it is important to consider that not all participants within a group responded uniformly. For example, Fig. 2 shows that exercise-induced changes in insulin sensitivity varied among individual participants, not only between but also within each intervention group. While individual responses to training vary, the underlying mechanisms for adaptations are likely uniform among individuals such that responses and adaptations should be proportional. This principle forms the basis of our analytical approach wherein we exploited the dynamic range of individual changes to identify clinical outcomes and metabolic intermediates that best track with one another. Lowering of plasma TGs was related to increases in many medium-and long-chain fatty acid-derived acylcarnitines, the Low/Moderate: low-amount moderate-intensity aerobic exercise; Low/Vigorous: low-amount vigorous-intensity aerobic exercise; High/Vigorous: highamount vigorous-intensity aerobic exercise; AT/RT: combination of low/vigorous aerobic exercise and RT *p<0.05 for change from baseline using paired t test amino acids alanine and proline and the TCA cycle intermediates citrate, succinate, fumarate, malate and α-ketoglutarate (R=0.2-0.3, p<0.05) ( Table 2) . Improvements in S I were related to increases in free carnitine and many of the lipid-derived acylcarnitines (R=0.2-0.3, p<0.05; Fig. 3 ; Table 2 ), Of note, the relationship between change in insulin sensitivity and free carnitine remained statistically significant even when excluding the outlier with a large (343%) response in free carnitine (R=0.2, p<0.05). Stronger associations were observed between changes in S I and the TCA cycle intermediates succinate, fumarate and α-ketoglutarate (R=0.2-0.4, p<0.05) ( Table 2) , as well as alanine, serine, methionine, glutamine/glutamate, ornithine, arginine and the C4-DC acylcarnitine species, which derives in part from succinyl-CoA.
Exercise-induced changes in muscle metabolites depended on intensity of the training regimen We found that the relationship between changes in muscle metabolite levels and clinical outcomes appeared to depend on the intensity of the training regimen, as much stronger and some directionally distinct associations emerged when the analyses were performed separately for the vigorous-(65-80% V ⋅ O 2peak ) compared with the moderate- Table 1 ). For example, for those performing vigorous-intensity training, associations were stronger between S I and free carnitine, several TCA cycle intermediates, as well as amino acids such as glycine, alanine, proline, leucine/ isoleucine, methionine, histidine, glutamine/glutamate, ornithine, citrulline and arginine (R =0.3-0.5, p <0.05 for all). Conversely, the same analysis abolished the relation between S I and most acylcarnitines, with the notable exception of C4-DC, succinylcarnitine (R=0.38, p<0.005). The relationships between change in S I and succinate, free carnitine, C4-DC/succinylcarnitine and leucine/isoleucine in the vigorous group are depicted in ESM Fig. 1 .
Exercise-induced changes in muscle metabolites correlated with transcriptional induction of fatty acid metabolism genes We hypothesised that fasting levels of fatty acidderived acylcarnitines might reflect muscle abundance of the enzymes that produce these metabolites. Also, we hypothesised that changes in succinate might be related to enzymes in the succinate dehydrogenase node (Fig. 4) . To test these hypotheses, we extracted data from our Affymetrix microarray analysis to examine training-induced regulation of a targeted set of 654 probes-corresponding to 495 genes-with functions in the following pathways: TCA cycle, β-oxidation, amino acid metabolism, ketone synthesis and degradation, lipid metabolism and trafficking, oxidative phosphorylation, branched-chain amino acid (BCAA) catabolism, succinate metabolism and glycine metabolism. The last three of these pathways were highlighted based on prior relationships that we observed between these metabolites and insulin action [8, 17] . We related changes in expression of genes associated with these pathways to changes in the metabolites. For those metabolites with changes most closely related to changes in V ⋅ O 2peak (C14:2) and S I (succinate), we selected the gene expression changes most related to the changes in metabolites. Gene selection proceeded from the gene related with the smallest p value to those with successively larger p values until a cumulative sum p value of 0.05 was reached. These 30 genes/probes were combined, arranged according to pathway involvement and a heat map showing R>0.3 and R<−0.3 was created. This process is depicted in Fig. 5 . The heat map presented in Fig. 6 shows that exerciseinduced increases in muscle acylcarnitines correlated Confidence in the reliability and specificity of this result comes from the finding that these gene/metabolite associations were specific for fatty acidderived metabolites, as changes in most amino and organic acids were unrelated to lipid-related genes selected for this analysis (Fig. 6 ). Exercise-induced increases in muscle succinate were correlated with upregulation of a similar set of genes involved in lipid metabolism as well as genes involved in oxidative phosphorylation (Fig. 6 ).
Discussion
To our knowledge, this is the first investigation to apply targeted, semi-quantitative metabolic profiling to examine metabolic signatures of exercise training in human skeletal muscle and how these relate to both clinical and gene expression responses to exercise training. We studied individuals at risk of cardiometabolic disease to identify metabolic correlates of training-induced improvements in clinical outcomes. Induction of muscle content of acylcarnitines emerged as the strongest metabolic biomarker of the trained state. These metabolites are generated by a family of mitochondrialocalised acyltransferase enzymes that convert acyl-CoA intermediates of fat and amino acid catabolism to their cognate carnitine esters. When substrate supply exceeds metabolic flux at specific catabolic enzymes, the resulting bottleneck leads to acyl-CoA accumulation and a concomitant rise in acylcarnitine production. In the present study, acylcarnitine concentrations measured in the fasted state (when fatty acid supply is plentiful) changed in concert with expression of nuclear-encoded genes that regulate fatty acid uptake and activation, lipid droplet metabolism and fatty acid transport into mitochondria. Most convincing was the finding that changes in muscle levels of lipid-derived acylcarnitines correlated strongly (R=0.3-0.7) with changes in abundance of mRNA of mitochondrial enzymes in the pathway for producing these metabolites. Thus, exerciseinduced reprogramming of mitochondrial metabolism was clearly evident at the metabolite level. Moreover, increased muscle concentrations of even-chain acylcarnitines, as well as several TCA cycle intermediates, were related to improved cardiorespiratory fitness (V ⋅ O 2peak ) and lowering of circulating TGs, suggesting that enhanced mitochondrial quantity and/or quality contributed to improved lipid clearance. A distinguishing and important feature of this study was the comparison of metabolic responses across six distinct interventions differing in amount and intensity of exercise. In some but not all cases, changes in muscle metabolite levels were dose responsive with respect to energy expenditure. Interestingly, the associations between metabolites and whole-body cardiometabolic fitness were modified according to the aerobic intensity (40-55% V ⋅ O 2peak vs 65-80% V ⋅ O 2peak )
of the exercise programmes. For example, although vigorousintensity aerobic training (65-80% V ⋅ O 2peak ) produced robust increases in several even-chain acylcarnitine species, this response was unrelated to changes in S I in the vigorous-intensity groups. Changes in aerobic fitness (V ⋅ O 2peak ) were likewise unrelated to S I , consistent with findings of our previous study [3, 18] . Taken together, these results imply that cardiorespiratory capacity and mitochondrial potential for β-oxidation were not primary drivers of improved insulin sensitivity in these cohorts. By contrast, increases in the fat-derived acylcarnitines were much more modest in response to moderate-intensity exercise training, but in this group several of the even-chain species correlated positively with S I . Although our power to interpret these analyses is clearly limited by the small sample size, the results suggest that moderate-vs vigorous-intensity activity might influence the metabolic network and S I via distinct biological mechanisms. At first glance, the results of the current study appear to conflict with previous reports identifying medium-and longchain acylcarnitines as metabolic markers of insulin resistance [19] [20] [21] [22] [23] . However, emerging evidence argues against the notion that acylcarnitines act as direct mediators of insulin resistance and instead suggests that the carnitine system defends against mitochondrial stress by buffering the local acyl-CoA pool [24] . Unlike their acyl-CoA precursors, the membranepermeant acylcarnitines can be shuttled between cellular compartments [24] . Thus, elevated acylcarnitines in the settings of obesity and diabetes could reflect an attempt to reroute carbon intermediates from mitochondria to other cellular or extracellular sites. Likewise, in the context of overnight fasting, lipid supply to inactive muscles exceeds metabolic demand. Therefore, we propose that the training-induced rise in fasting levels of long-and medium-chain acylcarnitines coincides with a more robust carnitine buffering system and enhanced capacity to cope with transient fluctuations in metabolic load.
Also notable was the finding that muscle concentrations of free carnitine, succinate and succinylcarnitine, along with several TCA cycle intermediates, emerged as strong, positive correlates of S I , particularly in the vigorous-intensity exercise groups. Although exercise training did not produce consistent increases in muscle levels of free carnitine and succinylcarnitine, participants in whom these metabolites increased tended to show greater improvement in S I (Fig. 3, ESM Fig. 1 ). Changes in free carnitine correlated strongly with changes in succinylcarnitine (R=0.71, p<0.001) and other short-chain carnitine esters, but not with changes in long-chain acylcarnitines. These findings align with recent reports showing that L-carnitine supplementation increased muscle production and efflux of short-chain acylcarnitines in accordance with improved glucose tolerance [20, 24] . Further evidence that mitochondrial acylcarnitine production and/or efflux benefits glucose homeostasis comes from studies showing that mice with muscle-specific deletion of carnitine acetyltransferase (CrAT), the enzyme that generates short-chain acylcarnitines, develop whole-body glucose intolerance [24] . CrAT acts on acyl-CoA species ranging from two to five carbons and is a potential source of the C4-DC carnitine species, which derives from both succinyl-CoA and methylmalonyl-CoA. In the present study, C4-DC correlated strongly with succinate, which derives from succinyl-CoA via succinate dehydrogenase (SDH). We therefore surmise that C4-DC could be reporting on succinyl-CoA. Intriguingly, network reconstruction of the muscle metabolites most strongly associated with improved S I pointed to the SDH complex as a potential regulatory hub that intersects with insulin action (Fig. 4) . The lack of strong succinate signature at the gene expression level suggests that the relationship between succinate and S I stems from changes in enzyme/protein activity, local energetics and/or metabolic flux rather than transcriptional regulation.
In addition to the aforementioned succinate and TCA cycle intermediates, improved insulin sensitivity was directly related to skeletal muscle concentrations of several amino acids including alanine, serine, methionine, glutamate/glutamine, ornithine and arginine. These associations were again most pronounced in the vigorous-intensity exercise group. Also, in this group, improvement in insulin sensitivity was related to increases in the BCAAs leucine and isoleucine. This positive relationship was somewhat surprising given that numerous studies in both rodents and humans have linked elevations in circulating BCAAs to insulin resistance and type 2 diabetes [12, 17, 25] . However, it is worth noting that in the previous studies obesity-related increases in peripheral blood BCAA levels were accompanied by a corresponding rise in the oddchain acylcarnitine byproducts of amino acid catabolism [12, 17, 25] . By contrast, in the muscle tissue from participants in the STRRIDE studies, changes in the C3 and C5 acylcarnitines did not track with their amino acid precursors. Thus, in the context of exercise training, especially during the period following the exercise stimulus (STRRIDE muscle samples were collected 16-24 h after the last exercise training bout), amino acids might be preferentially diverted towards muscle protein synthesis rather than mitochondrial energy production. Another interesting observation was that changes in muscle concentrations of leucine and alanine showed remarkably strong associations with changes in free carnitine and C4-DC (R=0.64-0.85, p<0.0001), thereby linking amino acid metabolism to the aforementioned SDH node.
In summary, this investigation identified a subset of skeletal muscle metabolic intermediates that track with exerciseinduced improvements in cardiometabolic fitness, including exercise capacity, circulating triacylglycerols and insulin sensitivity. It is important to emphasise that these measurements were made in the overnight fasted state when fatty acids and ketones, and perhaps amino acids, predominate as preferred mitochondrial substrates, and 16-24 h after the last exercise bout, when skeletal muscle metabolic anabolic activity is still relatively high and post-exercise lipid oxidation might continue. Still, despite robust training-induced increases in muscle content of lipid-derived acylcarnitines, these metabolites did not appear to exert a strong influence on insulin sensitivity. Instead, our analysis identified a more compelling connection between S I and succinate metabolism. SDH represents a unique metabolic node where the TCA cycle and electron transport chain converge with the pathways of ketone and amino acid catabolism. Also, SDH is thought to be an important control site for mitochondrial reactive oxygen species emission, which has been shown to influence insulin action in studies using transgenic mouse models [26] . Although the mechanistic relevance of these findings remains uncertain at this stage, the results offer new and provocative clues for further study. 
